These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 11187163)
1. [Prophylactic thyroidectomy in carriers of RET oncogene mutation carriers]. Høie J; Heimdal K; Nesland JM; Børmer O Tidsskr Nor Laegeforen; 2000 Nov; 120(27):3249-52. PubMed ID: 11187163 [TBL] [Abstract][Full Text] [Related]
2. Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations. Learoyd DL; Gosnell J; Elston MS; Saurine TJ; Richardson AL; Delbridge LW; Aglen JV; Robinson BG Clin Endocrinol (Oxf); 2005 Dec; 63(6):636-41. PubMed ID: 16343097 [TBL] [Abstract][Full Text] [Related]
3. [Prophylactic thyroidectomy in children who are carriers of a multiple endocrine neoplasia type 2 mutation: description of 20 cases and recommendations based on the literature]. de Groot JW; Links TP; Rouwe CW; van der Wal JE; Hofstra RM; Plukker JT Ned Tijdschr Geneeskd; 2006 Feb; 150(6):311-8. PubMed ID: 16503023 [TBL] [Abstract][Full Text] [Related]
4. Familial medullary carcinoma prevention, risk evaluation, and RET in children of families with MEN2. Moore SW; Appfelstaedt J; Zaahl MG J Pediatr Surg; 2007 Feb; 42(2):326-32. PubMed ID: 17270543 [TBL] [Abstract][Full Text] [Related]
5. [Management of multiple endocrine neoplasia syndrome type 2 families in association with rare germline mutations of the RET proto-oncogene]. Fitze G; Saeger HD; Roesner D; Schackert HK Klin Padiatr; 2004; 216(5):270-6. PubMed ID: 15455293 [TBL] [Abstract][Full Text] [Related]
7. Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A. Skinner MA; Moley JA; Dilley WG; Owzar K; Debenedetti MK; Wells SA N Engl J Med; 2005 Sep; 353(11):1105-13. PubMed ID: 16162881 [TBL] [Abstract][Full Text] [Related]
8. When is prophylactic thyroidectomy indicated for patients with the RET codon 609 mutation? Calva D; O'Dorisio TM; Sue O'Dorisio M; Lal G; Sugg S; Weigel RJ; Howe JR Ann Surg Oncol; 2009 Aug; 16(8):2237-44. PubMed ID: 19472011 [TBL] [Abstract][Full Text] [Related]
9. [Mutations of ret-proto-oncogene in thyroid medullary carcinoma]. Frank-Raue K; Höppner W; Buhr H; Herfarth C; Ziegler R; Raue F Dtsch Med Wochenschr; 1997 Feb; 122(6):143-9. PubMed ID: 9081799 [TBL] [Abstract][Full Text] [Related]
10. [Hereditary thyroid cancer can be cured by prophylactic surgery]. Wallin G; Bondesson AG; Farnebo LO; Hallengren B; Hamberger B; Jansson S; Nilsson O; Nordenskjöld M; Smeds S; Svensson KA; Wihlborg O; Zedenius J Lakartidningen; 2001 Jun; 98(25):3024-8. PubMed ID: 11462876 [TBL] [Abstract][Full Text] [Related]
11. Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma. Kinlaw WB; Scott SM; Maue RA; Memoli VA; Harris RD; Daniels GH; Porter DM; Belloni DR; Spooner ET; Ernesti MM; Noll WW Clin Endocrinol (Oxf); 2005 Dec; 63(6):676-82. PubMed ID: 16343103 [TBL] [Abstract][Full Text] [Related]
12. Prophylactic thyroidectomy in the treatment of thyroid medullary carcinoma. Age for surgery? Hassett S; Costigan C; McDermott M; Fitzgerald RJ Eur J Pediatr Surg; 2000 Oct; 10(5):334-6. PubMed ID: 11194546 [TBL] [Abstract][Full Text] [Related]
13. New presentation of familial medullary thyroid carcinoma in 87-year-old patient with high-risk RET proto-oncogene codon 620 mutation. Jaggard MK; MacRae C; Ifeacho S; Robinson S; Tolley NS J Laryngol Otol; 2009 Jul; 123(7):796-800. PubMed ID: 18771606 [TBL] [Abstract][Full Text] [Related]
14. RET gene mutations (genotype and phenotype) of multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma. Krampitz GW; Norton JA Cancer; 2014 Jul; 120(13):1920-31. PubMed ID: 24699901 [TBL] [Abstract][Full Text] [Related]
15. [Preventive thyroidectomy]. Norheim I Tidsskr Nor Laegeforen; 2000 Nov; 120(27):3235. PubMed ID: 11187158 [No Abstract] [Full Text] [Related]
17. Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto-oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal. Prazeres HJ; Rodrigues F; Figueiredo P; Naidenov P; Soares P; Bugalho MJ; Lacerda M; Campos B; Martins TC Clin Endocrinol (Oxf); 2006 Jun; 64(6):659-66. PubMed ID: 16712668 [TBL] [Abstract][Full Text] [Related]
18. Management of patients with hereditary medullary thyroid carcinoma. Fitze G Eur J Pediatr Surg; 2004 Dec; 14(6):375-83. PubMed ID: 15630638 [TBL] [Abstract][Full Text] [Related]
19. Late-onset medullary carcinoma of the thyroid: need for genetic testing and prophylactic thyroidectomy in adult family members. Shaha AR; Cohen T; Ghossein R; Tuttle RM Laryngoscope; 2006 Sep; 116(9):1704-7. PubMed ID: 16955009 [TBL] [Abstract][Full Text] [Related]
20. [C634R mutation of the protooncongene RET and molecular diagnosis in multiple endocrine neoplasia type 2 in a large Moroccan family]. Benazzouz B; Hafidi A; Benkhira S; Chraibi A; Kadiri A; Hilal L Bull Cancer; 2008 Apr; 95(4):457-63. PubMed ID: 18495576 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]